These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9484785)

  • 1. Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer.
    Miyake H; Hanada N; Nakamura H; Kagawa S; Fujiwara T; Hara I; Eto H; Gohji K; Arakawa S; Kamidono S; Saya H
    Oncogene; 1998 Feb; 16(7):933-43. PubMed ID: 9484785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model.
    Miyake H; Yamanaka K; Muramaki M; Hara I; Gleave ME
    Neoplasia; 2005 Feb; 7(2):171-9. PubMed ID: 15802022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic chemsensitization and inhibition of tumor growth and metastasis by the antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model.
    Miyake H; Hara I; Kamidono S; Gleave ME
    Clin Cancer Res; 2001 Dec; 7(12):4245-52. PubMed ID: 11751526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
    Chang FL; Ling YF; Lai MD
    Anticancer Res; 2000; 20(1A):329-36. PubMed ID: 10769676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic effects of Ad5CMV-p53 expression in two human nasopharyngeal carcinoma cell lines.
    Li JH; Li P; Klamut H; Liu FF
    Clin Cancer Res; 1997 Apr; 3(4):507-14. PubMed ID: 9815713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction of insulin-like growth factor binding protein-2 gene into human bladder cancer cells enhances their metastatic potential.
    Miyake H; Hara I; Yamanaka K; Muramaki M; Gleave M; Eto H
    Oncol Rep; 2005 Feb; 13(2):341-5. PubMed ID: 15643522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic chemosensitization and inhibition of tumor growth and metastasis by adenovirus-mediated P53 gene transfer in human bladder cancer model.
    Miyake H; Hara I; Hara S; Arakawa S; Kamidono S
    Urology; 2000 Aug; 56(2):332-6. PubMed ID: 10925118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of bcl-2 and bcl-X in bladder cancer.
    Kirsh EJ; Baunoch DA; Stadler WM
    J Urol; 1998 Apr; 159(4):1348-53. PubMed ID: 9507882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Bcl-2 enhances metastatic potential of human bladder cancer cells.
    Miyake H; Hara I; Yamanaka K; Gohji K; Arakawa S; Kamidono S
    Br J Cancer; 1999 Apr; 79(11-12):1651-6. PubMed ID: 10206273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of chemosensitivity in human bladder cancer cells by adenoviral-mediated p53 gene transfer.
    Miyake H; Hara I; Gohji K; Yamanaka K; Arakawa S; Kamidono S
    Anticancer Res; 1998; 18(4C):3087-92. PubMed ID: 9713515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced radiosensitivity by inhibition of the anti-apoptotic gene clusterin using antisense oligodeoxynucleotide in a human bladder cancer model.
    Yamanaka K; Gleave M; Muramaki M; Hara I; Miyake H
    Oncol Rep; 2005 May; 13(5):885-90. PubMed ID: 15809754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells.
    Yang HL; Dong YB; Elliott MJ; Liu TJ; McMasters KM
    Clin Cancer Res; 2000 Apr; 6(4):1579-89. PubMed ID: 10778992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma.
    Dole M; Nuñez G; Merchant AK; Maybaum J; Rode CK; Bloch CA; Castle VP
    Cancer Res; 1994 Jun; 54(12):3253-9. PubMed ID: 8205548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck.
    Liu TJ; el-Naggar AK; McDonnell TJ; Steck KD; Wang M; Taylor DL; Clayman GL
    Cancer Res; 1995 Jul; 55(14):3117-22. PubMed ID: 7606733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
    Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer.
    Hamada K; Alemany R; Zhang WW; Hittelman WN; Lotan R; Roth JA; Mitchell MF
    Cancer Res; 1996 Jul; 56(13):3047-54. PubMed ID: 8674061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic enhancement of resistance to cisplatin in human bladder cancer cells by overexpression of mutant-type p53 and Bcl-2.
    Miyake H; Hara I; Yamanaka K; Arakawa S; Kamidono S
    J Urol; 1999 Dec; 162(6):2176-81. PubMed ID: 10569615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Bcl-2 regulates sodium butyrate- and/or docetaxel-induced apoptosis in human bladder cancer cells both in vitro and in vivo.
    Miyake H; Hara S; Arakawa S; Kamidono S; Hara I
    Int J Cancer; 2001 Jul; 93(1):26-32. PubMed ID: 11391617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.
    Mueller T; Voigt W; Simon H; Fruehauf A; Bulankin A; Grothey A; Schmoll HJ
    Cancer Res; 2003 Jan; 63(2):513-21. PubMed ID: 12543810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.
    Dole MG; Jasty R; Cooper MJ; Thompson CB; Nuñez G; Castle VP
    Cancer Res; 1995 Jun; 55(12):2576-82. PubMed ID: 7780971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.